Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2014
08/21/2014WO2014125426A1 Trisubstituted heterocyclic derivatives as ror gamma modulators
08/21/2014WO2014125084A1 Hydroxyindalpine derivatives and their medical use
08/21/2014WO2014124651A1 Pyrrolidine-2-carboxylic acid derivatives as iglur antagonists
08/21/2014WO2014124560A1 Mglur regulators
08/21/2014WO2014100620A3 Compounds and methods for kinase modulation, and indications therefor
08/21/2014WO2014096388A3 Novel benzimidazole derivatives as kinase inhibitors
08/21/2014WO2014087298A4 Novel selective androgen receptor modulators
08/21/2014WO2014070888A8 Organic conductive materials and devices
08/21/2014US20140235865 Method for producing tetrazole-substituted anthranilic acid diamide derivatives by reacting pyrazolic acids with anthranilic acid esters
08/21/2014US20140235864 Biphenyl derivatives
08/21/2014US20140235862 Method for producing 4, 4-difluoro-3,4-dihydroisoquinoline derivatives
08/21/2014US20140235859 Process for the resolution of omeprazole
08/21/2014US20140235858 Neuroprotective multifunctional antioxidants and their monofunctional analogs
08/21/2014US20140235675 3-oxo-2,3-dihydro-1h-indazole-4-carboxamide derivatives as parp-1 inhibitors
08/21/2014US20140235673 Pyridinedione carboxamide inhibitors of endothelial lipase
08/21/2014US20140235671 Scriptaid isosteres and their use in therapy
08/21/2014US20140235658 Quinazoline derivatives as kinases inhibitors and methods of use thereof
08/21/2014US20140235654 Use of derivatives of indoles for the treatment of cancer
08/21/2014US20140235652 Pyridine Derivatives
08/21/2014US20140235646 Methods and Compositions for the Treatment of Body Weight Related Disorders
08/21/2014US20140235642 Trpm8 antagonists and their use in treatments
08/21/2014US20140235641 Pyrazole carboxamides as janus kinase inhibitors
08/21/2014US20140235640 Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors
08/21/2014US20140235639 Novel compounds
08/21/2014US20140235638 Anti-Infective Agents and Uses Thereof
08/21/2014US20140235636 N-acyloxysulfonamide and n-hydroxy-n-acylsulfonamide derivatives
08/21/2014US20140235633 4-Aminoquinazoline Derivatives and Uses Thereof
08/21/2014US20140235628 Inhibitors of the Renal Outer Medullary Potassium Channel
08/21/2014US20140235622 Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
08/21/2014US20140235614 Monocyclic pyridine derivative
08/21/2014US20140235611 Phenyl derivative
08/21/2014US20140235609 Carbamate/urea derivatives containing piperidin and piperazin rings as h3 receptor inhibitors
08/21/2014US20140235608 Pyridinedione carboxamide inhibitors of endothelial lipase
08/21/2014US20140235593 Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4-tetrahydroisoquinoline-4-carboxamides for antimalarial therapies
08/21/2014US20140234376 Substituted Benzoazepines as Toll-Like Receptor Modulators
08/21/2014US20140234333 Compositions and methods for inhibition of the jak pathway
08/20/2014EP2767534A1 New benzotriazole derivative and organic electroluminescent element in which said derivative is used
08/20/2014EP2767532A1 Novel compound for imaging tau protein accumulated in the brain
08/20/2014EP2766354A1 Protein kinase inhibitors
08/20/2014EP2766353A1 2-oxo-piperidinyl derivatives
08/20/2014EP2766352A1 Indazole compounds as kinase inhibitors and method of treating cancer with same
08/20/2014EP2766347A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
08/20/2014EP2766346A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
08/20/2014EP2766345A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
08/19/2014US8809549 Esters of bendamustine and related compounds, and medical use thereof
08/19/2014US8809545 Aryl pyridine as aldosterone synthase inhibitors
08/19/2014US8809543 Electrophotographic photoreceptor, electrophotographic image forming method, electrophotographic image forming apparatus, and process cartridge for electrophotographic image forming apparatus
08/19/2014US8809542 Salts of benzimidazole compound and use thereof
08/19/2014US8809528 Quinazolinone derivatives useful as vanilloid antagonists
08/19/2014US8809525 1,2,4-triazine-4-amine derivatives
08/19/2014US8809402 Oxazolone and pyrrolidinone-substituted biphenyls as P2X3 and P2X2/3 antagonists
08/19/2014US8809381 Highly selective sigma receptor ligands
08/19/2014US8809373 Pyridine non-classical cannabinoid compounds and related methods of use
08/19/2014US8809370 AMPK-activating heterocyclic compounds and methods for using the same
08/19/2014US8809369 Tetrahydroquinoline derivatives
08/19/2014US8809368 Compounds affecting gap junction activity
08/19/2014US8809367 1-1-Oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators
08/19/2014US8809365 1-substituted 2-azabicyclo [3.1.1] heptyl derivatives useful as nicotinic acetylcholine receptor modulators for treating neurologic disorders
08/19/2014US8809364 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors
08/19/2014US8809342 Glucagon receptor modulators
08/19/2014US8809339 Compounds and methods for inhibiting phosphate transport
08/19/2014US8809337 Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugs
08/19/2014US8809326 Isoquinolinone Rho kinase inhibitors
08/19/2014US8809323 Therapeutic applications of pro-apoptotic benzodiazepines
08/19/2014CA2724629C Tetrahydrocyclopenta[b]indole androgen receptor modulators
08/19/2014CA2654427C A novel process for the preparation of esomeprazole and salts thereof
08/19/2014CA2612265C 2-substituted benzimidazoles
08/14/2014WO2014124418A1 Modulators of methyl modifying enzymes, compositions and uses thereof
08/14/2014WO2014122670A1 Carbodithioates with spermicidal activity and process for preparation thereof
08/14/2014WO2014122474A1 Piperidin-1 -yl and azepin-1 -yl carboxylates as muscarinic m4 receptor agonists
08/14/2014WO2014122065A1 2-aminopyridine derivatives as plant growth regulating compounds
08/14/2014WO2014121885A1 Substituted quinoxaline derivatives and their use as positive allosteric modulators of mglur4
08/14/2014WO2014100719A3 Teatrahydro- and dihydro-isoquinoline prmt5 inhibitors and uses thereof
08/14/2014WO2014097151A3 Autotaxin inhibitors
08/14/2014US20140228578 Chiral Synthesis of Pyrrolidine Core Compounds en route to Neuronal Nitric Oxide Synthase Inhibitors
08/14/2014US20140228576 Method for producing 3,4-dihydroisoquinoline derivatives and production intermediates of same
08/14/2014US20140228410 P38map kinase inhibitors
08/14/2014US20140228409 Condensed heterocyclic compound
08/14/2014US20140228408 Novel rock kinase inhibitors
08/14/2014US20140228399 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
08/14/2014US20140228394 Inhibitors of cyp 17
08/14/2014US20140228392 Compositions and methods for treating cancer
08/14/2014US20140228387 Disubstituted 5-fluoro-pyrimidines
08/14/2014US20140228386 17a-HYDROXYLASE/C17,20-LYASE INHIBITORS
08/14/2014US20140228382 3-(5-substituted-4-oxoquinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same
08/14/2014US20140228378 N-(Benzimimdazol-2-yl)-Cyclopropane Carboxamides as Lysophosphatidic Acid Antagonists
08/14/2014US20140228374 Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
08/14/2014US20140228373 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
08/14/2014US20140228371 Quinoline and quinazoline amides as modulators of sodium channels
08/14/2014US20140228368 Pyrimidine pde10 inhibitors
08/14/2014US20140228367 Preparation and methods of use for ortho-aryl 5-membered heteroaryl-carboxamide containing multi-targeted kinase inhibitors
08/14/2014US20140228363 Tetrasubstituted cyclohexyl compounds as kinase inhibitors
08/14/2014US20140228362 Method of Treatment or Prophylaxis
08/14/2014US20140228361 Aminoquinazoline derivatives and their salts and methods of use
08/14/2014US20140228360 Prmt5 inhibitors and uses thereof
08/14/2014US20140228359 Bis-indolic derivatives, their uses in particular as antibacterials
08/14/2014US20140228358 Acyclic cyanoethylpyrazoles as janus kinase inhibitors
08/14/2014US20140228351 Substituted indazole derivatives active as kinase inhibitors
08/14/2014US20140228348 Cyanomethylpyrazole carboxamides as janus kinase inhibitors
08/14/2014US20140228343 Prmt5 inhibitors and uses thereof
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 1080